vimarsana.com

ஒரையந் காட்சி கார்டிகல் ப்ரோஸ்‌தெஸிஸ் அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Buzz Show: Second Sight Medical (NASDAQ: EYES) FDA Approval Argus 2s Retinal Prosthesis System | The Buzz Show: Second Sight Medical (NASDAQ: EYES) FDA Approval Argus 2s Retinal Prosthesis SystemFinancial Buzz

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Second Sight Medical Receives FDA Approval for the Argus 2s Retinal Prosthesis System” Second Sight Medical (NASDAQ: EYES) Products surged just under 60% in premarket trading after the company announced the U.S. Food and Drug Administration has approved the Argus 2s Retinal Prosthesis System. The Company expects that the redesigned set of external hardware initially for use in combination with previously implanted Argus II systems for the treatment of retinitis pigmentosa, will be adapted to be the external system for the next generation Orion Visual Cortical Prosthesis System, currently under development.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.